Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Vídeo
|
![]() |
Infectious diseasesPatty Fan-Havard; Ralph H Raasch; Jerry Blank; Nick Davis; Purdue University School of Pharmacy and Pharmacal Sciences; American Association of Colleges of Pharmacy Curricular Resources ClearinghouseWest Layfayette, Ind Purdue University School of Pharmacy and Pharmacal Sciences Alexandria, Va American Association of Colleges of Pharmacy c1992Item não circula. Consulte sua biblioteca.(Acessar) |
2 |
Material Type: Artigo
|
![]() |
Antiretroviral-drug concentrations in semen : Implications for sexual transmission of human immunodeficiency virus type 1KASHUBA, A. D. M ; DYER, J. R ; KRAMER, L. M ; RAASCH, R. H ; ERON, J. J ; COHEN, M. SAntimicrobial agents and chemotherapy, 1999-08, Vol.43 (8), p.1817-1826 [Periódico revisado por pares]Washington, DC: American Society for MicrobiologyTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Tolerance and Pharmacokinetic Interactions of Rifabutin and AzithromycinHAFNER, Richard ; BETHEL, James ; DRUSANO, George ; STANDIFORD, Harold C ; FOLLANSBEE, Stephen ; COHN, David L ; POLK, Ronald E ; MOLE, Larry ; RAASCH, Ralph ; KUMAR, Princy ; MUSHATT, DavidAntimicrobial Agents and Chemotherapy, 2001-05, Vol.45 (5), p.1572-1577 [Periódico revisado por pares]Washington, DC: American Society for MicrobiologyTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062)MOORE, K. H. P ; RAASCH, R. H ; BROUWER, K. L. R ; OPHEIM, K ; CHEESEMAN, S. H ; EYSTER, E ; LEMON, S. M ; VAN DER HORST, C. MAntimicrobial Agents and Chemotherapy, 1995-12, Vol.39 (12), p.2732-2737 [Periódico revisado por pares]Washington, DC: American Society for MicrobiologyTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Oxacillin-resistant Staphylococcus aureus endophthalmitis after ganciclovir intraocular implantWilliamson, John C ; Virata, Steven R ; Raasch, Ralph H ; Kylstra, Jan AAmerican journal of ophthalmology, 2000-04, Vol.129 (4), p.554-555 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Pyrimethamine pharmacokinetics in human immunodeficiency virus-positive patients seropositive for Toxoplasma gondiiJACOBSON, J. M ; DAVIDIAN, M ; RAINEY, P. M ; HAFNER, R ; RAASCH, R. H ; LUFT, B. JAntimicrobial Agents and Chemotherapy, 1996-06, Vol.40 (6), p.1360-1365 [Periódico revisado por pares]Washington, DC: American Society for MicrobiologyTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Nosocomial infections in the ICU: the growing importance of antibiotic-resistant pathogensWeber, D J ; Raasch, R ; Rutala, W AChest, 1999-03, Vol.115 (3 Suppl), p.34S-41S [Periódico revisado por pares]United StatesTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Effects of Intraluminal Epidermal Growth Factor on Mucosal Proliferation in the Small Intestine of Adult RatsUlshen, Martin H. ; Lyn-Cook, Lascelles E. ; Raasch, Ralph H.Gastroenterology (New York, N.Y. 1943), 1986-11, Vol.91 (5), p.1134-1140 [Periódico revisado por pares]New York, NY: Elsevier IncTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Discontinuation rates for protease inhibitor regimens containing ritonavir 600 mg versus ritonavir 400 mg plus saquinavir 400 mgRublein, JC ; Eron JJ, , Jr ; Butts, JD ; Raasch, RHThe Annals of pharmacotherapy, 1999-09, Vol.33 (9), p.899-905 [Periódico revisado por pares]Cincinnati, OH: Harvey Whitney BooksTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Treatment and prophylaxis of disseminated Mycobacterium avium complex in HIV-infected individualsFaris, MA ; Raasch, RH ; Hopfer, RL ; Butts, JDAnnals of Pharmacotherapy, 1998-05, Vol.32 (5), p.564-573 [Periódico revisado por pares]Cincinnati, OH: Harvey Whitney BooksTexto completo disponível |